Posts by: Iqra Mumal

The U.S. Food and Drug Administation has granted orphan designation to Mallinckrodt Pharmaceuticals‘ drug candidate MNK-1411 for treatment of Duchenne Muscular Dystrophy (DMD). MNK-1411 is an injection composed of a formulation ... Read more

July 12, 2017July 12, 2017

Problems in RNA Processing Seen to Lead to Congenital Myotonic Dystrophy in Early Study

News

The molecular process that leads to congenital myotonic dystrophy (CMD) in infants and children was identified by researchers working with tissue samples and mice. Their study, titled “Disrupted prenatal RNA processing and ... Read more